Evidence map›Paper›PMID 30530711›Full record

ArticleApplied and environmental microbiology2019

Discovery of 16-Demethylrifamycins by Removing the Predominant Polyketide Biosynthesis Pathway in

Qiang Zhou, Guang-Cai Luo, Huizhan Zhang, Gong-Li Tang

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Nanoscaled Discovery of a Shunt Rifamycin fromACS infectious diseases · 2023
    Article
  4. Review
  5. Article
  6. A NewMarine drugs · 2021
    Article
  7. Synthetic biology enabling access to designer polyketides.Current opinion in chemical biology · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Qiang ZhouDepartment of Applied Biology, East China University of Science and Technology, Shanghai, China.
Guang-Cai LuoState Key Laboratory of Bio-organic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
Huizhan ZhangDepartment of Applied Biology, East China University of Science and Technology, Shanghai, China huizhzh@ecust.edu.cn gltang@sioc.ac.cn.
Gong-Li TangState Key Laboratory of Bio-organic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China huizhzh@ecust.edu.cn gltang@sioc.ac.cn.
Chinese Academy of Sciences · CNEast China University of Science and Technology · CNShanghai Institute of Organic Chemistry · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of strategies have been developed to mine novel natural products based on biosynthetic gene clusters and there have been dozens of successful cases facilitated by the development of genomic sequencing. During our study on biosynthesis of the antitumor polyketide kosinostatin (KST), we found that the genome of

Indexed as

Drug DiscoveryAminoglycosidesAnti-Bacterial AgentsBase SequenceBiosynthetic PathwaysGene DeletionLactams, MacrocyclicMicromonosporaMultigene FamilyPolyketidesRifamycinsSecondary MetabolismAF 013AminoglycosidesAnti-Bacterial AgentskosinostatinLactams, MacrocyclicPolyketidesRifamycinsansamycinscross talkgenome miningmetabolic flux redirectionrifamycin

Identifiers

PMID30530711
PMCPMC6365818
OpenAlexW2903877193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.